Small Business Administration
Notice is hereby given that Escalate Capital V, LP, 6300 Bridgepoint Parkway, Bldg. 1, Suite 489, Austin, TX 78730, Federal Licensees under the Small Business Investment Act of 1958, as amended (“the Act”), in connection with financings of a small business, has sought an exemption under Section 312 of the Act and 13 CFR 107.730, Financings which Constitute Conflicts of Interest of the Code of Federal Regulations.
The financing is brought within the purview of 13 CFR 107.730(a) of the regulations because Escalate Capital V, LP (“Licensee”) proposes to provide financing to Vivo Care, Inc. 6300 Bridgepoint Parkway, Building 1, Suite 480, Austin, TX 78730, to support its acquisition in Onpoint Healthcare Partners, Inc. through a stock-for-stock merger in which Vivo Care, Inc, will be the surviving entity and Onpoint Healthcare Partners, Inc, merges into Vivo Care Inc. Escalate Capital IV, LP is an Associate of the Licensee by way of Common Control, and has a greater than ten percent ownership interest in Vivo Care, Inc. Therefore, this transaction is considered a financing which constitutes a conflict of interest.
Notice is hereby given that any interested person may submit written comments on the transaction, within fifteen days of the date of this publication, to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street SW, Washington, DC 20416.
Paul Salgado,
Director, Investment Portfolio Management, Office of Investment and Innovation.